Alnylam Pharmaceuticals, Inc. financial data

Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, Massachusetts
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 315 % -13.1%
Quick Ratio 10.4 % -35.8%
Debt-to-equity -1.57K % +65.6%
Return On Equity 131 % -90.5%
Return On Assets -8.92 % +71.1%
Operating Margin -75.7 % +9.84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126M shares +1.58%
Common Stock, Shares, Outstanding 126M shares +1.79%
Entity Public Float 23.7B USD +34.4%
Common Stock, Value, Issued 1.27M USD +1.77%
Weighted Average Number of Shares Outstanding, Basic 126M shares +1.63%
Weighted Average Number of Shares Outstanding, Diluted 126M shares +1.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.04B USD +22.9%
Revenue from Contract with Customer, Excluding Assessed Tax 2B USD +75.2%
Research and Development Expense 1.03B USD +9.66%
Costs and Expenses 2.18B USD +12.8%
Operating Income (Loss) -176M USD +77.7%
Nonoperating Income (Expense) -149M USD +45.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -325M USD +69.4%
Income Tax Expense (Benefit) 7.33M USD +49.2%
Net Income (Loss) Attributable to Parent -332M USD +68.8%
Earnings Per Share, Basic -2.64 USD/shares +69.7%
Earnings Per Share, Diluted -2.64 USD/shares +69.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 682M USD +1.43%
Accounts Receivable, after Allowance for Credit Loss, Current 321M USD +46.5%
Inventory, Net 94M USD -28.7%
Assets, Current 2.99B USD +17.6%
Property, Plant and Equipment, Net 523M USD +0.08%
Operating Lease, Right-of-Use Asset 195M USD -9.11%
Other Assets, Noncurrent 67.5M USD +6.32%
Assets 3.82B USD +12.7%
Accounts Payable, Current 78.1M USD +25.6%
Employee-related Liabilities, Current 122M USD -6.52%
Accrued Liabilities, Current 699M USD +37.4%
Contract with Customer, Liability, Current 76.9M USD +115%
Liabilities, Current 942M USD +39.8%
Contract with Customer, Liability, Noncurrent 186M USD -3.01%
Operating Lease, Liability, Noncurrent 238M USD -8.32%
Other Liabilities, Noncurrent 320M USD +42.8%
Liabilities 4.04B USD +10.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -27M USD +31%
Retained Earnings (Accumulated Deficit) -7.08B USD -4.92%
Stockholders' Equity Attributable to Parent -219M USD +15.4%
Liabilities and Equity 3.82B USD +12.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -81.5M USD +51%
Net Cash Provided by (Used in) Financing Activities 28.9M USD -37.7%
Net Cash Provided by (Used in) Investing Activities -67.6M USD +11.3%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 126M shares +1.79%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -130M USD +33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 685M USD +1.53%
Interest Paid, Excluding Capitalized Interest, Operating Activities 30.9M USD +122%
Deferred Tax Assets, Valuation Allowance 2.82B USD +28.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 2.9B USD +26.3%
Operating Lease, Liability 285M USD -6.16%
Depreciation 51.6M USD +32%
Payments to Acquire Property, Plant, and Equipment 13M USD -6.61%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -320M USD +70%
Lessee, Operating Lease, Liability, to be Paid 418M USD -9.15%
Property, Plant and Equipment, Gross 749M USD +7.49%
Operating Lease, Liability, Current 41.7M USD -3.21%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.4M USD -0.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 43.6M USD +1.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -713K USD +50.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 133M USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 40.6M USD -5.18%
Deferred Tax Assets, Operating Loss Carryforwards 803M USD 0%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 7.44M USD +32.9%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 39M USD -3.39%
Operating Lease, Payments 46.5M USD +7.89%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 4M USD
Current Federal Tax Expense (Benefit) 4.02M USD
Share-based Payment Arrangement, Expense 227M USD -5.89%
Interest Expense 128M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%